Literature DB >> 17264942

High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.

Mohamed Baba-Ahmed1, Grégoire Le Gal, Francis Couturaud, Karine Lacut, Emmanuel Oger, Christophe Leroyer.   

Abstract

Among candidate risk factors associated with postoperative venous thromboembolism (VTE), the role of factorV Leiden (FVL) mutation remains unclear. We performed a case-control study to assess the potential significance of FVL mutation in postoperative VTE cases despite prophylaxis. We used data from the ongoing case-control "EDITH" study. We extracted 133VTE cases and 144 controls who had undergone either surgery or had plaster cast in the previous three months. Prophylaxis adequacy with regard to the recommendations published by the American College of Chest Physicians was retrospectively assessed. FVL mutation was present in 20VTE cases and four controls (OR 5.9, 95% CI 2-18). Prophylaxis was judged as adequate in 116 cases (88.5%) and in 129 controls (87.2%) (p=0.66). The frequency of FVL mutation was not different in VTE cases occurring while on adequate prophylaxis and in VTE cases occurring after the end of adequate prophylaxis (p=0.27). FVL mutation was closely associated with postoperative VTE in patients classified as having received an adequate prophylaxis (8.4; 95% CI, 2.4 to 29). This study shows a close association between the presence of factorV Leiden mutation in symptomatic VTE occurring after surgery despite prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264942

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Mortality after laparoscopic adjustable gastric banding: results from an anonymous questionnaire to ASBS members.

Authors:  Michel Gagner; Luca Milone; Nelson Trelles
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

2.  Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.

Authors:  Juergen Ringwald; Annika Berger; Werner Adler; Cornelia Kraus; Rocco P Pitto
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

3.  Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk.

Authors:  Jihye Kim; Peter Kraft; Kaitlin A Hagan; Laura B Harrington; Sara Lindstroem; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2018-03-08       Impact factor: 2.135

Review 4.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

5.  Prevalence of factor V Leiden in south Tunisian blood donors.

Authors:  Lobna Maalej; Basma Hadjkacem; Ikram Ben Amor; Mariem Smaoui; Ali Gargouri; Jalel Gargouri
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 6.  [Diagnostic assessment of perioperative thromboembolism].

Authors:  Thomas Lang
Journal:  Wien Med Wochenschr       Date:  2009-10

7.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.